Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keith C. Cheng is active.

Publication


Featured researches published by Keith C. Cheng.


Science | 2005

SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans.

Rebecca L. Lamason; Manzoor Ali P K Mohideen; Jason R. Mest; Andy Wong; Heather L. Norton; Michele C. Aros; Michael J. Jurynec; Xianyun Mao; Vanessa R. Humphreville; Jasper E. Humbert; Soniya Sinha; Jessica L. Moore; Pudur Jagadeeswaran; Wei Zhao; Gang Ning; Izabela Makalowska; Paul McKeigue; David H. O'Donnell; Rick A. Kittles; Esteban J. Parra; Nancy J. Mangini; David Grunwald; Mark D. Shriver; Victor A. Canfield; Keith C. Cheng

Lighter variations of pigmentation in humans are associated with diminished number, size, and density of melanosomes, the pigmented organelles of melanocytes. Here we show that zebrafish golden mutants share these melanosomal changes and that golden encodes a putative cation exchanger slc24a5 (nckx5) that localizes to an intracellular membrane, likely the melanosome or its precursor. The human ortholog is highly similar in sequence and functional in zebrafish. The evolutionarily conserved ancestral allele of a human coding polymorphism predominates in African and East Asian populations. In contrast, the variant allele is nearly fixed in European populations, is associated with a substantial reduction in regional heterozygosity, and correlates with lighter skin pigmentation in admixed populations, suggesting a key role for the SLC24A5 gene in human pigmentation.


Advances in Cancer Research | 1992

Genomic Instability and Tumor Progression: Mechanistic Considerations

Keith C. Cheng; Lawrence A. Loeb

Publisher Summary This chapter discusses the mechanics of genomic instability and the way the phenotype of genomic instability predisposes to cancer and accelerates tumor progression. The large number of genomic instability genes suggests that the probability of some people in the human population carrying a recessive mutation in a genomic instability gene is high. Cell size and cell death affect the number of genomic instability mutations that are expected in a tumor. The impact of individual genomic instability mutations on tumor progression is dependent upon active cell division. Some examples of disruption of these pathways leading to genomic instability are also considered in the chapter by a selective survey of cellular mechanisms involved in maintaining genomic stability. The large number of components involved in those mechanisms may increase the likelihood that disruption of normal genomic stability mechanisms will occur during a normal lifespan and during the growth of benign neoplasms. Various factors that can affect the frequency of genomic instability mutations are also considered in the chapter. These mechanisms suggest ways to delay or prevent certain types of cancer. The genomic alterations identified in human cancers can be viewed by cellular pathways dedicated to the maintenance of genomic stability.


Experimental Gerontology | 2002

Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio)

Glenn S. Gerhard; Elizabeth J. Kauffman; Xujun Wang; Richard Stewart; Jessica L. Moore; Claudia J. Kasales; Eugene Demidenko; Keith C. Cheng

Zebrafish have become a widely used model organism in developmental biology research. In order to initiate an experimental foundation for aging studies, we have determined some basic gerontological parameters for populations of outbred zebrafish, and the golden sparse strain. Outbred zebrafish manifested a mean life span of about 42 months, with the longest living individual surviving for 66 months. The golden sparse populations had a mean life span of 36 months and a maximum longevity of 58 months. Skeletal length at death increased with age, suggestive of indeterminate growth. A common age-related phenotype was spinal curvature. Radiographic analysis excluded bony changes as the cause of the spinal curvature, suggesting muscle abnormalities as a primary mechanism. These data and a growing abundance of related biological resources suggest that the zebrafish may be a compelling model organism for studies on aging.


Brain | 2008

Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease

William J. Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J. Skvorak; Harbhajan S. Paul; Gregg E. Homanics; Maria C. Bewley; Keith C. Cheng; Kathryn F. LaNoue; John M. Flanagan

Maple syrup urine disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism presenting with life-threatening cerebral oedema and dysmyelination in affected individuals. Treatment requires life-long dietary restriction and monitoring of branched-chain amino acids to avoid brain injury. Despite careful management, children commonly suffer metabolic decompensation in the context of catabolic stress associated with non-specific illness. The mechanisms underlying this decompensation and brain injury are poorly understood. Using recently developed mouse models of classic and intermediate maple syrup urine disease, we assessed biochemical, behavioural and neuropathological changes that occurred during encephalopathy in these mice. Here, we show that rapid brain leucine accumulation displaces other essential amino acids resulting in neurotransmitter depletion and disruption of normal brain growth and development. A novel approach of administering norleucine to heterozygous mothers of classic maple syrup urine disease pups reduced branched-chain amino acid accumulation in milk as well as blood and brain of these pups to enhance survival. Similarly, norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease. Current findings suggest two converging mechanisms of brain injury in maple syrup urine disease including: (i) neurotransmitter deficiencies and growth restriction associated with branched-chain amino acid accumulation and (ii) energy deprivation through Krebs cycle disruption associated with branched-chain ketoacid accumulation. Both classic and intermediate models appear to be useful to study the mechanism of brain injury and potential treatment strategies for maple syrup urine disease. Norleucine should be further tested as a potential treatment to prevent encephalopathy in children with maple syrup urine disease during catabolic stress.


Journal of Clinical Investigation | 2007

Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I

William J. Zinnanti; Jelena Lazovic; Cathy Housman; Kathryn F. LaNoue; James P. O'Callaghan; Ian A. Simpson; Michael Woontner; Stephen I. Goodman; James R. Connor; Russell E. Jacobs; Keith C. Cheng

Glutaric acidemia type I (GA-I) is an inherited disorder of lysine and tryptophan metabolism presenting with striatal lesions anatomically and symptomatically similar to Huntington disease. Affected children commonly suffer acute brain injury in the context of a catabolic state associated with nonspecific illness. The mechanisms underlying injury and age-dependent susceptibility have been unknown, and lack of a diagnostic marker heralding brain injury has impeded intervention efforts. Using a mouse model of GA-I, we show that pathologic events began in the neuronal compartment while enhanced lysine accumulation in the immature brain allowed increased glutaric acid production resulting in age-dependent injury. Glutamate and GABA depletion correlated with brain glutaric acid accumulation and could be monitored in vivo by proton nuclear magnetic resonance (1H NMR) spectroscopy as a diagnostic marker. Blocking brain lysine uptake reduced glutaric acid levels and brain injury. These findings provide what we believe are new monitoring and treatment strategies that may translate for use in human GA-I.


Journal of Forensic Sciences | 2010

Predicting Phenotype from Genotype: Normal Pigmentation*

Robert K. Valenzuela; S B S Miquia Henderson; H B S Monica Walsh; Nanibaa’ A. Garrison; T B S Jessica Kelch; Orit Cohen-Barak; Drew T. Erickson; F. John Meaney; J. Bruce Walsh; Keith C. Cheng; Shosuke Ito; Kazumasa Wakamatsu; Tony Frudakis; Matthew Thomas; Murray H. Brilliant

Abstract:  Genetic information in forensic studies is largely limited to CODIS data and the ability to match samples and assign them to an individual. However, there are circumstances, in which a given DNA sample does not match anyone in the CODIS database, and no other information about the donor is available. In this study, we determined 75 SNPs in 24 genes (previously implicated in human or animal pigmentation studies) for the analysis of single‐ and multi‐locus associations with hair, skin, and eye color in 789 individuals of various ethnic backgrounds. Using multiple linear regression modeling, five SNPs in five genes were found to account for large proportions of pigmentation variation in hair, skin, and eyes in our across‐population analyses. Thus, these models may be of predictive value to determine an individual’s pigmentation type from a forensic sample, independent of ethnic origin.


Laboratory Investigation | 2000

Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio).

Lee G. Beckwith; Jessica L. Moore; Gladys S. Tsao-Wu; John C Harshbarger; Keith C. Cheng

The zebrafish (Danio rerio) has been successfully used to discover hundreds of genes involved in development and organogenesis. To address the potential of zebrafish as a cancer model, it is important to determine the susceptibility of zebrafish to tumors. Germ line mutations are most commonly induced for zebrafish mutant screens by exposing adult male zebrafish to the alkylating agent, ethylnitrosourea (ENU). To determine whether ENU induces tumors, we compared the incidence of tumors in ENU-treated fish with untreated controls. Interestingly, 18 of 18 (100%) fish mutagenized with either 2.5 or 3.0 mm ENU developed epidermal papillomas, which numbered 1 to 22 per fish, within 1 year of treatment. The induced epidermal lesions included epidermal hyperplasia, flat papillomas (0.2 to 1.2 mm), and pedunculated papillomas (1.2 to 8 mm in greatest dimension), but no skin cancers. Angiogenesis was evident in papillomas larger than approximately 1 mm. All but two papillomas contained the three cell types (keratinocytes, club, and mucous cells) of normal zebrafish epidermis; histologic variants lacked either club cells or mucous cells. Two cavernous hemangiomas and a single malignant peripheral nerve sheath tumor were also found in the treated fish. None of five untreated controls developed tumors. These studies establish the feasibility of the zebrafish as an experimental model for the study of skin tumors.


Genetics | 2006

Zebrafish Genomic Instability Mutants and Cancer Susceptibility

Jessica L. Moore; Lindsay M. Rush; Carol Breneman; Manzoor-Ali P.K. Mohideen; Keith C. Cheng

Somatic loss of tumor suppressor gene function comprising the second hit of Knudsons two-hit hypothesis is important in human cancer. A genetic screen was performed in zebrafish (Danio rerio) to find mutations that cause genomic instability (gin), as scored by Streisingers mosaic-eye assay that models this second hit. The assay, based on a visible test for loss of wild-type gene function at a single locus, golden, is representative of genomewide events. Twelve ENU-induced genomic instability (gin) mutations were isolated. Most mutations showed weak dominance in heterozygotes and all showed a stronger phenotype in homozygotes. Trans-heterozygosity for 7 of these mutations showed greatly enhanced instability. A variety of spontaneous tumors were found in heterozygous adults from all gin lines, consistent with the expectation that genomic instability (mutator) mutations can accelerate carcinogenesis. The incidence of spontaneous cancer at 30–34 months was increased 9.6-fold in heterozygotes for the mutant with the strongest phenotype, gin-10. Tumors were seen in skin, colon, kidney, liver, pancreas, ovary, testis, and neuronal tissues, with multiple tumors in some fish. The study of these mutants will add to our understanding of the mechanisms of somatic loss of gene function and how those mechanisms contribute to cancer susceptibility.


Cancer Research | 2004

Shark Cartilage, Cancer and the Growing Threat of Pseudoscience

Gary K. Ostrander; Keith C. Cheng; Jeffrey C. Wolf; Marilyn J. Wolfe

The promotion of crude shark cartilage extracts as a cure for cancer has contributed to at least two significant negative outcomes: a dramatic decline in shark populations and a diversion of patients from effective cancer treatments. An alleged lack of cancer in sharks constitutes a key justification for its use. Herein, both malignant and benign neoplasms of sharks and their relatives are described, including previously unreported cases from the Registry of Tumors in Lower Animals, and two sharks with two cancers each. Additional justifications for using shark cartilage are illogical extensions of the finding of antiangiogenic and anti-invasive substances in cartilage. Scientific evidence to date supports neither the efficacy of crude cartilage extracts nor the ability of effective components to reach and eradicate cancer cells. The fact that people think shark cartilage consumption can cure cancer illustrates the serious potential impacts of pseudoscience. Although components of shark cartilage may work as a cancer retardant, crude extracts are ineffective. Efficiencies of technology (e.g., fish harvesting), the power of mass media to reach the lay public, and the susceptibility of the public to pseudoscience amplifies the negative impacts of shark cartilage use. To facilitate the use of reason as the basis of public and private decision-making, the evidence-based mechanisms of evaluation used daily by the scientific community should be added to the training of media and governmental professionals. Increased use of logical, collaborative discussion will be necessary to ensure a sustainable future for man and the biosphere.


Current Opinion in Genetics & Development | 2011

Whole-animal Imaging, Gene Function, and the Zebrafish Phenome Project

Keith C. Cheng; Xuying Xin; Darin P. Clark; Patrick J. La Riviere

Imaging can potentially make a major contribution to the Zebrafish Phenome Project, which will probe the functions of vertebrate genes through the generation and phenotyping of mutants. Imaging of whole animals at different developmental stages through adulthood will be used to infer biological function. Cell resolutions will be required to identify cellular mechanism and to detect a full range of organ effects. Light-based imaging of live zebrafish embryos is practical only up to ∼2 days of development, owing to increasing pigmentation and diminishing tissue lucency with age. The small size of the zebrafish makes possible whole-animal imaging at cell resolutions by histology and micron-scale tomography (microCT). The histological study of larvae is facilitated by the use of arrays, and histologys standard use in the study of human disease enhances its translational value. Synchrotron microCT with X-rays of moderate energy (10-25 keV) is unimpeded by pigmentation or the tissue thicknesses encountered in zebrafish of larval stages and beyond, and is well-suited to detecting phenotypes that may require 3D modeling. The throughput required for this project will require robotic sample preparation and loading, increases in the dimensions and sensitivity of scintillator and CCD chips, increases in computer power, and the development of new approaches to image processing, segmentation, and quantification.

Collaboration


Dive into the Keith C. Cheng's collaboration.

Top Co-Authors

Avatar

Victor A. Canfield

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Jessica L. Moore

University of South Florida

View shared research outputs
Top Co-Authors

Avatar

Brian A. Canada

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Georgia K. Thomas

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

James Ze Wang

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Khai Chung Ang

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

William J. Zinnanti

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

James R. Connor

Penn State Milton S. Hershey Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jean E. Copper

Pennsylvania State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge